Showing results (1841-1850 of 2,011) with videos related to

Sort By:
Pageof 202
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 StudySanja Dacic, William D Travis, Jennifer M Giltnane, et al.
Cancer Research|August 1, 1983
Association of the human type C retrovirus with a subset of adult T-cell cancersR C Gallo, V S Kalyanaraman, M G Sarngadharan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2021
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphomaS Horwitz, O A O'Connor, B Pro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)Dara L Aisner, Lynette M Sholl, Lynne D Berry, et al.
JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.
Cancer Research|July 13, 2018
Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial DysplasiaDaniel T Merrick, Michael G Edwards, Wilbur A Franklin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2024
Lung cancer research and treatment: global perspectives and strategic calls to actionM-L Meyer, S Peters, T S Mok, et al.
Journal of Pregnancy|February 18, 2016
Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative StudyJudith G M Jelsma, Karen M van Leeuwen, Nicolette Oostdam, et al.
Journal of Multimorbidity and Comorbidity|February 3, 2025
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospitalMiles D Witham, Victoria Bartle, Sue Bellass, et al.
Nature Medicine|September 13, 2022
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trialJamie E Chaft, Filiz Oezkan, Mark G Kris, et al.
Pageof 202